KKRS

KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061$16.41+0.01 (+0.06%)

Prev Close$16.40·MCap$15.46B·P/E—·Vol27.8K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$116.83M

◆

Net Activity

Net Seller

$116.83M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061 (KKRS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 1 insider sale totaling $116.83M. The most recent insider transaction was by ROBERTS GEORGE R (Co-Executive Chairman), who sold $116.83M worth of shares on Aug 7, 2025. KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061 operates in the Financial Services sector, within the Financial - Credit Services industry, with a market cap of $15.46B.

KKRS Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 7, 2025	ROBERTS GEORGE R	Co-Executive Chairman	Sell	809,906	$144.25	$116.83M	0
Jun 10, 2025	KKR Group Partnership L.P.		Sell	11,600,000	$14.40	$167.04M1.3% OS	21,533,124-35%
Jun 2, 2025	KRAVIS HENRY R	Co-Executive Chairman	Sell	1,281,394	$119.99	$153.76M	73,006,024
Jun 2, 2025	ROBERTS GEORGE R	Co-Executive Chairman	Sell	1,190,094	$119.80	$142.57M	82,171,888
May 27, 2025	BARAKETT TIMOTHY R		Buy	35,000	$117.92	$4.13M	185,000
May 14, 2025	KKR Genetic Disorder L.P.		Sell	6,000,000	$34.20	$205.20M0.7% OS	13,260,971-31%
May 8, 2025	SCULLY ROBERT W		Buy	13,250	$113.49	$1.50M	13,250
Mar 11, 2025	KKR Group Partnership L.P.		Sell	2,948,723	$9.91	$29.22M	0Exit
Mar 7, 2025	KKR Genetic Disorder L.P.		Sell	6,000,000	$32.96	$197.76M0.7% OS	19,260,972
Mar 30, 2021	KKR Group Partnership L.P.		Sell	3,700,000	$32.25	$119.33M	9,749,189-28%
Mar 18, 2021	KKR Group Partnership L.P.		Sell	304,141	$46.20	$14.05M	3,086,585
Mar 3, 2021	KKR Group Partnership L.P.		Sell	2,075,424	$46.20	$95.88M	3,217,986-39%

KKRS Insider Buying Activity

The following table shows recent insider purchases of KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061 (KKRS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 27, 2025	BARAKETT TIMOTHY R		Buy	35,000	$117.92	$4.13M	185,000
May 8, 2025	SCULLY ROBERT W		Buy	13,250	$113.49	$1.50M	13,250

KKRS Insider Selling Activity

The following table shows recent insider sales of KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061 (KKRS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 7, 2025	ROBERTS GEORGE R	Co-Executive Chairman	Sell	809,906	$144.25	$116.83M	0
Jun 10, 2025	KKR Group Partnership L.P.		Sell	11,600,000	$14.40	$167.04M1.3% OS	21,533,124-35%
Jun 2, 2025	KRAVIS HENRY R	Co-Executive Chairman	Sell	1,281,394	$119.99	$153.76M	73,006,024
Jun 2, 2025	ROBERTS GEORGE R	Co-Executive Chairman	Sell	1,190,094	$119.80	$142.57M	82,171,888
May 14, 2025	KKR Genetic Disorder L.P.		Sell	6,000,000	$34.20	$205.20M0.7% OS	13,260,971-31%
Mar 11, 2025	KKR Group Partnership L.P.		Sell	2,948,723	$9.91	$29.22M	0Exit
Mar 7, 2025	KKR Genetic Disorder L.P.		Sell	6,000,000	$32.96	$197.76M0.7% OS	19,260,972
Mar 30, 2021	KKR Group Partnership L.P.		Sell	3,700,000	$32.25	$119.33M	9,749,189-28%
Mar 18, 2021	KKR Group Partnership L.P.		Sell	304,141	$46.20	$14.05M	3,086,585
Mar 3, 2021	KKR Group Partnership L.P.		Sell	2,075,424	$46.20	$95.88M	3,217,986-39%